http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8de08e915c363b8cfe3bb3b521268936
Outgoing Links
Predicate | Object |
---|---|
family-name | van Berkel |
name | Theo JC van Berkel Theo J.C. van Berkel Theo J.C van Berkel |
given-name | Theo J.C. Theo JC Theo J.C |
organization-name | From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Sylvius Laboratories, Leiden University, Leiden, The Netherlands (J.H.v.d.T., T.J.C.v.B., E.A.L.B.); and the Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands (J.H.v.d.T.). From the Division of Biopharmaceutics (J.H.v.d.T., T.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research; Molecular Virology Group, Department of Molecular Cell Biology (R.C.H.) and Department of Cardiology (J.H.v.d.T.), Leiden University Medical Center; and TNO-PG (B.J.M.v.V., L.M.H.), Leiden, the Netherlands; and Department of Pathology (M.M.K.), Middelheim Academic Hospital, Antwerp, Belgium. From the Division of Biopharmaceutics (I.B., S.C.A.d.J., T.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, Leiden, the Netherlands; Institute of Molecular Cardiovascular Research (A.Z., C.W.), University Hospital, Rheinisch-Westfälische Technische Hochschule, Aachen, Germany; Wihuri Research Institute (K.A.L.), Helsinki, Finland. From the Division of Biopharmaceutics (E.J.A.v.W., S.C.A.d.J., T.v.E., P.d.V., E.A.L.B., T.J.C.v.B., J.K.), Leiden/Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands; and UCB (H.L.B., D.A.O., R.J.W., G.A.C.), Granta Park, Great Abington, Cambridge, UK. From the Division of Biopharmaceutics (I.B., S.C.A.d.J., M.B., S.H.v.H., T.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University; Departments of Cardiology (P.d.G.) and Pathology (R.W.V.), Medisch Centrum Haaglanden, The Hague; Department of Pathology (J.H.v.d.T.), Academic Medical Center, Amsterdam; and Experimental Vascular Pathology Group (E.A.L.B.), Department of Pathology, University of Maastricht, The Netherlands. From the Division of Biopharmaceutics (E.J.A.v.W., G.H.M.v.P., P.d.V., T.J.C.v.B., J.K.), Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden, The Netherlands; and the Department of Immunology (H.Y.), Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan. From Experimental Vascular Pathology Group, Department of Pathology, CARIM, Maastricht University Medical Center, The Netherlands (I.M., J.S., I.W., V.H., M.G., J.C., E.A.L.B.); Division of Biopharmaceutics, Leiden Academic Center for Drug Research, Leiden University, The Netherlands (I.M., I.B., S.C.A.d.J., T.J.C.v.B.); CNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France (C.C., I.M.-P.); Université de Toulouse, France (C.C., I.M.-P.); Institute for Prevention of... the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands. Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, 2333CC Leiden, Netherlands 1 From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research (J.H.v.d.T., M.L.F., T.J.C.v.B., E.A.L.B.), Gorlaeus Laboratories, Department of Cardiology, Leiden University Medical Centre (J.H.v.d.T.), and Crucell Holland B.V. (R.P., A.J.v.Z., V.M.), 2333 CN Leiden, The Netherlands. From the Pharma Division, Preclinical Research, Hoffmann–La Roche Ltd, Basel, Switzerland (M.A. van der K., E.M. von der M., O.H.M.), and the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, University of Leiden, Leiden, the Netherlands (M.A. van der K., J.K.K., A. van V., Th.J.C. van B.). From the Department of General Surgery, Maastricht University, Maastricht, the Netherlands (F.M.E.S.); Division of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom (H.Y.); Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, Leiden, the Netherlands (F.M.E.S., T.J.M.M., P.P., T.J.C.v.B., E.A.L.B.); Department of Material Science, Graduate School of Engineering, Nagoya Institute of Technology, Gokiso-chou, Nagoya... From the Pharma Division (M.A. van der K., O.H.M., H.J.K.), Preclinical Research, F Hoffmann–La Roche Ltd, Basel, Switzerland, and the Division of Biopharmaceutics (M.A. van der K., T.J.C. van B.), Leiden/Amsterdam Center for Drug Research, University of Leiden, Leiden, Netherlands. From the Departments of Biopharmaceutics (B.J.M.v.V., G.G., L.S.M.B., M.v.E., T.J.C.v.B.) and Toxicology (A.L.F., B.v.d.W.), Leiden/Amsterdam Center for Drug Research, Leiden/Amsterdam Center for Drug Research, Leiden, the Netherlands; TNO Prevention and Health (B.J.M.v.V., G.G., A.L.F., L.S.M.B., L.M.H.), Gaubius Laboratory, Leiden, the Netherlands; Department of Pathology AZ-Middelheim (M.M.K.), University of Antwerp, Antwerp, Belgium; and Departments of Human Genetics (M.J.G.), Immunohematology... From the Division of Biopharmaceutics (I.B., J.H.v.d.T., M.L.F., S.C.A.d.J., Th.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, Leiden, the Netherlands; John P. Robarts Research Institute (A.L.), Vascular Biology Research Group, University of Western Ontario, London, Ontario, Canada; and the Department of Pathology (M.M.P.C.D., S.H., M.J.A.P.D.), Cardiovascular Research Institute Maastricht, University of Maastricht, the Netherlands. From the Division of Biopharmaceutics, Leiden Academic Center for Drug Research, Leiden, the Netherlands (S.C.A.d.J., I.B., A.O.K., S.J.A.K., M.B., P.J.v.S., T.J.C.v.B., J.K., E.A.L.B.); Department of Cardiology, Leiden University Medical Center, the Netherlands (A.O.K.); Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands (S.J.A.K.); and Experimental Vascular Pathology group, Department of Pathology, CARIM, Academic... From the Division of Biopharmaceutics (H.Y., I.B., M.B., S.H.v.H., T.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, Leiden University, Leiden, the Netherlands; Leiden Institute of Chemistry (K.S., X.X., G.A.v.d.M., H.O.), Gorlaeus Laboratories, Leiden University, Leiden, the Netherlands; Division of Cardiovascular Medicine (M.R.B.), University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom; Department of Pathology (E.A.L.B.), University Hospital Maastricht,... Division of Biopharmaceutics, Sylvius Laboratory, Leiden/Amsterdam Center for Drug Research, University of Leiden, Leiden, The Netherlands From the Division of Biopharmaceutics (E.J.A.v.W., H.H., A.H., P.d.V., T.J.C.v.B., J.K.), Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden, The Netherlands; and the Department of Bioorganic Chemistry (T.I.), Graduate School of Pharmaceutical Sciences, Osaka University, and the Department of Oncology (H.F.), Osaka University Graduate School of Medicine, Osaka, Japan. Leiden University, Division of Biopharmaceutics, Leiden, The Netherlands. From the Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics (M.L.E.M., N.B., P.R., M.A.P., M.R.H.), University of British Columbia, and Child & Family Research Institute, Vancouver, BC, Canada; the Division of Biopharmaceutics,Leiden/Amsterdam Center for Drug Research (M.v.E., R.B.H., T.J.C.v.B.), Gorlaeus Laboratories, Leiden University, The Netherlands; James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research (B.W.C.W., B.M.M.), St. Paul’s Hospital,... From the Division of Biopharmaceutics (H.Y., T.J.C.v., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, Leiden University, the Netherlands; and Leiden Institute of Chemistry (K.S., H.O., G.A.v.), Gorlaeus Laboratories, Leiden University, the Netherlands. From the Division of Biopharmaceutics (P.C.N.R., L.A.J.M.S., P.J.v.S., M.F., S.H.v.L., T.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, University of Leiden, Gorlaeus Laboratory, Leiden; the Department of Industrial Design (H.N.J.S.), Delft University of Technology, Delft; Central Clinical Chemical Laboratory of the Leiden University Medical Center (J.H.M.S.), Leiden; and the Department of General Internal Medicine (P.C.N.R. current address), Leiden University Medical Center, Leiden... the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, University of Leiden (E.A.L.B., M.v.T., H.V., M.K.B., T.J.C.v.B., J.K.), and Gaubius Laboratory, TNO Prevention and Health (M.M.B.-B., D.C.R.), Leiden, The Netherlands. From the Division of Biopharmaceutics (A.D.H., G.H.M.P., N.P., P.d.V., E.J.A.v.W., E.A.L.B., T.J.C.v.B., J.K.), Leiden University, The Netherlands; the Department of Biosciences, TNO Quality of Life, Gaubius Laboratory, and the Department of Vascular Surgery (V.v.W., P.H.A.Q.), LUMC, Leiden, the Netherlands; the Department of Radiation Oncology (A.G.N.), Heidelberg School of Medicine, Heidelberg, Germany; and The Scripps Research Institute (R.A.R.), La Jolla, Calif. From the Einthoven Laboratory of Experimental Vascular Medicine (E.P.v.d.V., R.G.d.B., M.R.d.V., S.T., J.M.v.G., M.K.R., C.M.B., C.v.S., H.C.d.B., E.A.P., R.B., T.J.R., P.H.A.Q., J.W.J, A.J.v.Z.), and the Departments of Nephrology (E.P.v.d.V., R.G.d.B., J.M.v.G., M.K.R., C.v.S., H.C.d.B., R.B., T.J.R., A.J.v.Z.), Cardiology (A.O.K., S.T., J.S., M.J.S., A.A.F.d.V., J.W.J), Surgery (M.R.d.V., I.B., E.A.P., P.H.A.Q.), Pulmonology (T.P., P.S.H.), and Molecular and Cellular Biology (M.J.G.), Leiden... From the Division of Biopharmaceutics (C.C.M.A., B.C.H.L., T.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, Leiden University, Gorlaeus Laboratories, Leiden, the Netherlands, and Center for Molecular and Vascular Biology (A.B., K.D., M.F.H), University of Leuven, Leuven, Belgium. From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands (F.M.E.S., I.B., E.P.v.d.V., T.J.C.v.B., E.A.L.B.); Department of Anatomy and Embryology (B.d.A., L.M.v.d.G., R.E.P., L.v.d.W.), Department of Radiology (L.v.d.W.), and Department of Human Genetics (L.v.d.W.), Leiden University Medical Center, Leiden, The Netherlands; Department of Research, Guerbet Group, Aulnay-sous-Bois, France (W.G., I.R.); Department of Medical... From the Division of BioTherapeutics, Leiden Academic Centre for Drug Research, The Netherlands (M.H., R.J.v.d.S., R.B.H., B.L., Y.Z., T.J.C.v.B., M.v.E.) |
Incoming Links
Total number of triples: 133.